HeartSciences (HSCS) Free Cash Flow (2021 - 2026)
HeartSciences filings provide 6 years of Free Cash Flow readings, the most recent being -$1.5 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 10.31% to -$1.5 million in Q1 2026 year-over-year; TTM through Jan 2026 was -$7.3 million, a 1.57% increase, with the full-year FY2025 number at -$7.4 million, down 20.89% from a year prior.
- Free Cash Flow hit -$1.5 million in Q1 2026 for HeartSciences, up from -$2.3 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$966278.0 in Q1 2022 to a low of -$2.3 million in Q4 2025.
- Median Free Cash Flow over the past 5 years was -$1.6 million (2025), compared with a mean of -$1.6 million.
- Biggest five-year swings in Free Cash Flow: plummeted 153.52% in 2022 and later increased 23.21% in 2025.
- HeartSciences' Free Cash Flow stood at -$1.1 million in 2022, then increased by 8.33% to -$990139.0 in 2023, then tumbled by 120.53% to -$2.2 million in 2024, then fell by 6.9% to -$2.3 million in 2025, then skyrocketed by 37.75% to -$1.5 million in 2026.
- The last three reported values for Free Cash Flow were -$1.5 million (Q1 2026), -$2.3 million (Q4 2025), and -$2.0 million (Q3 2025) per Business Quant data.